Noninvasive prenatal testing: Limitations and unanswered questions

Genetics in Medicine

Volumn 16, Issue 4, 2014, Pages 281-285

  Lutgendorf, Monica A ^a   Stoll, Katie A ^a   Knutzen, Dana M ^a   Foglia, Lisa M ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

aneuploidy; cell free DNA; genetic counseling; noninvasive prenatal screening; noninvasive prenatal testing

Indexed keywords

ANEUPLOIDY; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HIGH RISK PATIENT; HUMAN; INFORMED CONSENT; NON INVASIVE PROCEDURE; PATIENT COUNSELING; PRENATAL DIAGNOSIS; QUALITY CONTROL; REVIEW; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE; ECONOMICS; FEMALE; FETAL DISEASES; GENETIC SCREENING; GENETICS; LEGISLATION AND JURISPRUDENCE; PREGNANCY; PROCEDURES;

ANEUPLOIDY; FEMALE; FETAL DISEASES; GENETIC TESTING; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84898464885     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2013.126     Document Type: Review

References (31)

1. Moise KJ Jr, Argoti PS. Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol 2012;120:1132-1139.
2. Dennis Lo Y, Chiu RW. Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications. J Pathol 2011;225:318-323.
3. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008;105:16266-16271.
4. Sparks AB, Wang ET, Struble CA, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012;32:3-9.
5. Smith M, Visootsak J. Noninvasive screening tools for Down syndrome: a review. Int J Womens Health 2013;5:125-131.
6. Zimmermann B, Hill M, Gemelos G, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012;32:1233-1241.
7. Malone FD, Canick JA, Ball RH, et al.; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-2011.
8. Chen EZ, Chiu RW, Sun H, et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS ONE 2011;6:e21791.
9. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP; MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
10. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-920.
11. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14:296-305.
12. ACOG Committee Opinion 545. Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012;120:1532-1534.
13. Devers PL, Cronister A, Ormond KE, Facio F, Brasington CK, Flodman P. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Couns 2013;22:291-295.
14. Benn P, Borrell A, Crossley J, et al.; International Society for Prenatal Diagnosis. Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011. Prenat Diagn 2011;31:519-522.
15. Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013;15:395-398.
16. Fairbrother G, Johnson S, Musci TJ, Song K. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population. Prenat Diagn 2013;33:580-583.
17. Nicolaides KH, Syngelaki A, Ashoor G, Birdir C, Touzet G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012;207:374.e1-374.e6.
18. Choi H, Lau TK, Jiang FM, et al. Fetal aneuploidy screening by maternal plasma DNA sequencing: 'false positive' due to confined placental mosaicism. Prenat Diagn 2013;33:198-200.
19. Pan M, Li FT, Li Y, et al. Discordant results between fetal karyotyping and noninvasive prenatal testing by maternal plasma sequencing in a case of uniparental disomy 21 due to trisomic rescue. Prenat Diagn 2013;33:598-601.
20. Ledbetter DH, Zachary JM, Simpson L, et al. Cytogenetic results from the US Collaborative Study on CVS. Prenat Diagn 1992;12:317-345.
21. Stetten G, Escallon CS, South ST, McMichael JL, Saul DO, Blakemore KJ. Reevaluating confined placental mosaicism. Am J Med Genet A 2004;131:232-239.
22. Masuzaki H, Miura K, Yoshiura KI, Yoshimura S, Niikawa N, Ishimaru T. Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism. J Med Genet 2004;41:289-292.
23. Kalousek DK, Vekemans M. Confined placental mosaicism. J Med Genet 1996;33:529-533.
24. Artan S, Basaran N, Hassa H, et al. Confined placental mosaicism in term placentae: analysis of 125 cases. Prenat Diagn 1995;15:1135-1142.
25. Jensen TJ, Dzakula Z, Deciu C, van den Boom D, Ehrich M. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem 2012;58:1148-1151.
26. Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
27. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e1-205.11.
28. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207:137.e1-137.e8.
29. Ashoor G, Syngelaki A, Poon LC, Rezende JC, Nicolaides KH. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 2013;41:26-32.
30. Norton ME, Rose NC, Benn P. Noninvasive prenatal testing for fetal aneuploidy clinical assessment and a plea for restraint. Obstet Gyencol 2013;121(4):847-850.
31. Weaver C. Tough calls on prenatal tests. The Wall Street Journal 2013:B1.